Paula Pyle, MD
Otolaryngology · Venice, FLNPI 1043290950
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $751 of the $874 with a category attached, or 85.9%. 8 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 41.9% of the total. That places this record below the midpoint for otolaryngology clinicians in FL, where the typical reported total is $1,552.
Across 33 payments — averaging $26.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$366
- Sanofi$203
- Integra Lifesciences Corporation$87
- Optinose US, Inc.$84
- GSK$61
- Acclarent, Inc$35
- plus $38 from 2 others
What the payments were for
- Food & beverage$75186%
- Education$12314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $366 |
| Sanofi | 7 | $203 |
| Integra Lifesciences Corporation | 3 | $87 |
| Optinose US, Inc. | 4 | $84 |
| GSK | 3 | $61 |
| Acclarent, Inc | 1 | $35 |
| Merck | 1 | $23 |
| Medtronic | 1 | $15 |
How this compares
$874 in reported general payments places this provider in the 35th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 65 | $1,753 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,153 |
| Fluticasone Propionate | 69 | $873 |
| Azelastine Hcl | 11 | $579 |
| Omeprazole | 22 | $328 |
| Mometasone Furoate | 29 | $229 |
| Doxycycline Hyclate | 18 | $153 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $144 |
| Ciprofloxacin Hcl | 11 | $119 |
| Methylprednisolone | 16 | $106 |
| Prednisone | 57 | $95 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Venice
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
- John WestineGainesville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.